To explore the consequence of PTEN protein reduction in a PIK3CA mutant background, as well as the influence on signalling through PI3Kα and AKT more broadly, isogenic pairs of PIK3CA altered ER+ BC cells with and without PTEN deletion were used. The gene discussed is PIK3CA; the disease is breast cancer.